Plug and Play” mRNA technology works fast, updating vaccines in months : Oregon Health News Blog
Real-World Association Between mRNA Vaccination and Infection From the Omicron Strain of SARS-CoV-2: A Population-Level Analysis - AJPM Focus
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis | Nature Medicine
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study - The Lancet Respiratory Medicine
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice - ScienceDirect
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis | Nature Medicine
Vaccines | Free Full-Text | mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Three mRNA COVID-19 vaccine doses very effective in protecting against emergency department visits and hospitalizations associated with Omicron and Delta variants
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study | The BMJ
Centers for Disease Control and Prevention on LinkedIn: CDC recommends Novavax's non-mRNA booster for people ages 18 and older…
Study backs efficacy of half-dosage mRNA booster| สำนักข่าวกรมประชาสัมพันธ์
India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose - The Hindu
COVID-19 mRNA booster provides additional protection, most beneficial for older adults
Chinese mRNA COVID booster stronger against Omicron than Sinovac shot -trial data | Reuters
Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios | Reuters
CDC - UPDATED: CDC updated booster recommendations for... | Facebook
Vaccines | Free Full-Text | Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
CDC - COVID-19 BOOSTER UPDATE: Everyone ages 18+ is eligible for a COVID-19 booster. If you got an mRNA vaccine, either Pfizer-BioNTech or Moderna, you may get a booster dose 6 months
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Third COVID-19 mRNA vaccine booster dose indicated for myelofibrosis patients
Moderna on X: "Today, we shared positive pre-clinical data demonstrating our ability to combine 6 mRNAs against 3 different respiratory viruses in 1 vaccine: COVID-19 booster + Flu booster + RSV booster. #
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study - The Lancet Infectious Diseases
